{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:28Z","timestamp":1792787788618,"version":"4.5.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Research Project on Improving the Level of Clinical Evidence for Traditional Chinese Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences","award":["No. XYZX020107"],"award-info":[{"award-number":["No. XYZX020107"]}],"id":[{"id":"https:\/\/ror.org\/042pgcv68","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences","award":["No. CI2021A01911"],"award-info":[{"award-number":["No. CI2021A01911"]}],"id":[{"id":"https:\/\/ror.org\/042pgcv68","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04887-x","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:06:57Z","timestamp":1790165217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanoparticle delivery of Chinese medicine monomers for remodeling the colorectal cancer immune microenvironment"],"prefix":"10.1186","volume":"21","author":[{"given":"Meilin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanye","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfang","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"2","key":"4887_CR1","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","volume":"43","author":"R Abedizadeh","year":"2024","unstructured":"Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev. 2024;43(2):729\u201353.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"4887_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336.","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"4887_CR3","doi-asserted-by":"publisher","first-page":"103669","DOI":"10.1016\/j.drudis.2023.103669","volume":"28","author":"M Al Zein","year":"2023","unstructured":"Al Zein M, Boukhdoud M, Shammaa H, Mouslem H, El Ayoubi LM, Iratni R, et al. Immunotherapy and immunoevasion of colorectal cancer. Drug Discov Today. 2023;28(9):103669.","journal-title":"Drug Discov Today"},{"issue":"3","key":"4887_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/cells13030245","volume":"13","author":"PW Underwood","year":"2024","unstructured":"Underwood PW, Ruff SM, Pawlik TM. Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer. Cells. 2024;13(3):245.","journal-title":"Cells"},{"key":"4887_CR5","doi-asserted-by":"crossref","unstructured":"Wang J, Yu S, Qian L, Wu Y, Zhang W, Awadasseid A. Small-Molecule Inhibitors Targeting PD-1\/PD-L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical Prospects. ChemMedChem. 2025:e202500738.","DOI":"10.1002\/cmdc.202500738"},{"key":"4887_CR6","doi-asserted-by":"publisher","first-page":"101851","DOI":"10.1016\/j.tranon.2023.101851","volume":"40","author":"X Chen","year":"2024","unstructured":"Chen X, Chen LJ, Peng XF, Deng L, Wang Y, Li JJ, et al. Anti-PD-1\/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations. Transl Oncol. 2024;40:101851.","journal-title":"Transl Oncol"},{"issue":"1","key":"4887_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-025-02322-8","volume":"10","author":"Z Yuan","year":"2025","unstructured":"Yuan Z, Shi S, Weng S. Dual-immunotherapy triumphs: redefining deficient mismatch repair or high microsatellite instability metastatic colorectal cancer first-line treatment. Signal Transduct Target Ther. 2025;10(1):234.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4887_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/DCR.0000000000003845","volume":"68","author":"Q Sui","year":"2025","unstructured":"Sui Q, Liao L, Yu J, Zhang L, Xiao B, Jiang W, et al. Surgical Outcomes in Metastatic Mismatch Repair-Deficient\/Microsatellite Instability-High Colorectal Cancer After Disease Control With Immune Checkpoint Inhibitors: A Retrospective Observational Study. Dis Colon Rectum. 2025;68(9):1052\u201361.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"4887_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2021.06.005","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, Zou Y, Song L, Han S, Yang H, Chu D, et al. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharm Sin B. 2022;12(1):378\u201393.","journal-title":"Acta Pharm Sin B"},{"issue":"38","key":"4887_CR10","doi-asserted-by":"publisher","first-page":"e2405886","DOI":"10.1002\/advs.202405886","volume":"11","author":"X Ye","year":"2024","unstructured":"Ye X, Liu Y, Wei L, Sun Y, Zhang X, Wang H, et al. Monocyte\/Macrophage-Mediated Transport of Dual-Drug ZIF Nanoplatforms Synergized with Programmed Cell Death Protein-1 Inhibitor Against Microsatellite-Stable Colorectal Cancer. Adv Sci (Weinh). 2024;11(38):e2405886.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4887_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/PPO.0000000000000303","volume":"24","author":"TS Nowicki","year":"2018","unstructured":"Nowicki TS, Hu-Lieskovan S, Ribas A. Mechanisms of Resistance to PD-1 and PD-L1 Blockade. Cancer J. 2018;24(1):47\u201353.","journal-title":"Cancer J"},{"issue":"4","key":"4887_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","volume":"17","author":"JD Martin","year":"2020","unstructured":"Martin JD, Cabral H, Stylianopoulos T, Jain RK. Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges. Nat Rev Clin Oncol. 2020;17(4):251\u201366.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"4887_CR13","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.4049\/jimmunol.0803806","volume":"182","author":"X Ma","year":"2009","unstructured":"Ma X, Serna A, Xu RH, Sigal LJ. The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation. J Immunol. 2009;182(8):4601\u20137.","journal-title":"J Immunol"},{"issue":"11","key":"4887_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7(11):653\u201364.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"4887_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ptr.5984","volume":"32","author":"S Javadi","year":"2018","unstructured":"Javadi S, Rostamizadeh K, Hejazi J, Parsa M, Fathi M. Curcumin mediated down-regulation of \u03b1(V) \u03b2(3) integrin and up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) in Erlotinib resistant SW480 colon cancer cells. Phytother Res. 2018;32(2):355\u201364.","journal-title":"Phytother Res"},{"key":"4887_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers16193410","volume":"16","author":"A Ghebremedhin","year":"2024","unstructured":"Ghebremedhin A, Athavale D, Zhang Y, Yao X, Balch C, Song S. Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment. Cancers (Basel). 2024;16:19.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4887_CR17","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1021\/acsbiomaterials.4c02220","volume":"11","author":"MM Ansari","year":"2025","unstructured":"Ansari MM, Yadav V, Dighe S, Kuche K, Kanika, Khan R, et al. Co-Delivery of Glycyrrhizin and Paclitaxel via Gelatin-Based Core-Shell Nanoparticles Ameliorates 1,2-Dimethylhydrazine-Induced Precancerous Lesions in Colon. ACS Biomater Sci Eng. 2025;11(2):942\u201357.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"4887_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/nano13010107","volume":"13","author":"P Dana","year":"2022","unstructured":"Dana P, Thumrongsiri N, Tanyapanyachon P, Chonniyom W, Punnakitikashem P, Saengkrit N. Resveratrol Loaded Liposomes Disrupt Cancer Associated Fibroblast Communications within the Tumor Microenvironment to Inhibit Colorectal Cancer Aggressiveness. Nanomaterials (Basel). 2022;13(1):107.","journal-title":"Nanomaterials (Basel)"},{"issue":"1","key":"4887_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13046-023-02688-z","volume":"42","author":"L Long","year":"2023","unstructured":"Long L, Xiong W, Lin F, Hou J, Chen G, Peng T, et al. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery. J Exp Clin Cancer Res. 2023;42(1):117.","journal-title":"J Exp Clin Cancer Res"},{"key":"4887_CR20","doi-asserted-by":"publisher","first-page":"1642091","DOI":"10.3389\/fimmu.2025.1642091","volume":"16","author":"Q He","year":"2025","unstructured":"He Q, Xiang L, Luo Y, Wang R, Zheng C, Gao Y, et al. Tumor-associated macrophages in colon cancer immunotherapy: mechanisms, natural product interventions, and microenvironment remodeling. Front Immunol. 2025;16:1642091.","journal-title":"Front Immunol"},{"issue":"11","key":"4887_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00432-024-06022-8","volume":"150","author":"W Yuan","year":"2024","unstructured":"Yuan W, Zhang J, Chen H, Zhuang Y, Zhou H, Li W, et al. Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review. J Cancer Res Clin Oncol. 2024;150(11):502.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"Pt 2","key":"4887_CR22","doi-asserted-by":"publisher","first-page":"148941","DOI":"10.1016\/j.ijbiomac.2025.148941","volume":"335","author":"S Eldurini","year":"2026","unstructured":"Eldurini S, Tolba E, Abd El-Hady BM, Ibrahim AM, Shafaa MW. Liposome-chondroitin sulfate\/chitosan hybrid system for combinational drug delivery of curcumin and dexamethasone: In vitro anti-cancer activities. Int J Biol Macromol. 2026;335(Pt 2):148941.","journal-title":"Int J Biol Macromol"},{"key":"4887_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/nu17193085","volume":"17","author":"CY Lew","year":"2025","unstructured":"Lew CY, Tang YT, Lee AY, Chin ZJ, Chang WL, Chen CH, et al. Shikonin as a Dietary Phytochemical with Multi-Target Anti-Cancer Activities: From Molecular Mechanisms to Translational Applications. Nutrients. 2025;17:19.","journal-title":"Nutrients"},{"key":"4887_CR24","doi-asserted-by":"publisher","first-page":"114895","DOI":"10.1016\/j.colsurfb.2025.114895","volume":"255","author":"W Li","year":"2025","unstructured":"Li W, Fu Y, Yan S, Sun J, Yang C, Wang Y. Construction and evaluation of pH-sensitive nanoparticles with resveratrol release to trigger the immunogenic cell death in colon cancer cellsin vitro. Colloids Surf B Biointerfaces. 2025;255:114895.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4887_CR25","doi-asserted-by":"publisher","first-page":"101611","DOI":"10.1016\/j.mtbio.2025.101611","volume":"31","author":"D Lei","year":"2025","unstructured":"Lei D, Wang W, Zhao J, Zhou Y, Chen Y, Dai J, et al. An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment. Mater Today Bio. 2025;31:101611.","journal-title":"Mater Today Bio"},{"issue":"1","key":"4887_CR26","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s12672-025-03079-w","volume":"16","author":"Y Fu","year":"2025","unstructured":"Fu Y, Ge Y, Yi S, Peng Q, Jiang H, Zhou J. A review of synergistic strategies in cancer therapy: resveratrol-loaded hydrogels for targeted and multimodal treatment. Discov Oncol. 2025;16(1):1382.","journal-title":"Discov Oncol"},{"issue":"25","key":"4887_CR27","doi-asserted-by":"publisher","first-page":"15448","DOI":"10.1039\/D5NR01337B","volume":"17","author":"A Xia","year":"2025","unstructured":"Xia A, Yuan W, Xu S, Wu T, Yan W, Cao Y, et al. A prebiotic inulin derivative-containing liposome for oral berberine delivery improves the orthotopic colorectal cancer chemotherapy. Nanoscale. 2025;17(25):15448\u201363.","journal-title":"Nanoscale"},{"issue":"6","key":"4887_CR28","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1158\/1055-9965.EPI-07-0022","volume":"16","author":"DJ Boocock","year":"2007","unstructured":"Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1246\u201352.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"20","key":"4887_CR29","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","volume":"10","author":"RA Sharma","year":"2004","unstructured":"Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847\u201354.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4887_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1248\/bpb.34.660","volume":"34","author":"H Sasaki","year":"2011","unstructured":"Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, et al. Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull. 2011;34(5):660\u20135.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"4887_CR31","doi-asserted-by":"publisher","first-page":"24863","DOI":"10.1038\/s41598-026-53709-8","volume":"16","author":"DS Kim","year":"2026","unstructured":"Kim DS, Kim HK, Ha KC, Jang GH, Park SH, Kim DH, et al. Enhanced bioavailability of a novel double-layered nano-liposomal curcumin (BNT-C060): a randomized, double-blind, clinical trial. Sci Rep. 2026;16(1):24863.","journal-title":"Sci Rep"},{"key":"4887_CR32","doi-asserted-by":"publisher","first-page":"1795543","DOI":"10.3389\/fonc.2026.1795543","volume":"16","author":"J Chen","year":"2026","unstructured":"Chen J, Pan B, Cao X, Li Y, Tu Z, Ma C, et al. An emerging targeted strategy for gastric cancer: the multi-pathway regulatory potential of Chinese medicine monomers. Front Oncol. 2026;16:1795543.","journal-title":"Front Oncol"},{"key":"4887_CR33","doi-asserted-by":"publisher","first-page":"e19332","DOI":"10.7717\/peerj.19332","volume":"13","author":"B Song","year":"2025","unstructured":"Song B, Shuang L, Zhang S, Tong C, Chen Q, Li Y, et al. Research progress of nano drug delivery systems in the anti-tumor treatment of traditional Chinese medicine monomers. PeerJ. 2025;13:e19332.","journal-title":"PeerJ"},{"issue":"46","key":"4887_CR34","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.3748\/wjg.v28.i46.6497","volume":"28","author":"P Gogoi","year":"2022","unstructured":"Gogoi P, Kaur G, Singh NK. Nanotechnology for colorectal cancer detection and treatment. World J Gastroenterol. 2022;28(46):6497\u2013511.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4887_CR35","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1007\/s12010-023-04696-3","volume":"196","author":"AAZ Dezfuli","year":"2024","unstructured":"Dezfuli AAZ, Abu-Elghait M, Salem SS. Recent Insights into Nanotechnology in Colorectal Cancer. Appl Biochem Biotechnol. 2024;196(7):4457\u201371.","journal-title":"Appl Biochem Biotechnol"},{"issue":"5","key":"4887_CR36","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s13346-024-01707-6","volume":"15","author":"M Babaei","year":"2025","unstructured":"Babaei M, Abrishami A, Iranpour S, Saljooghi AS, Matin MM. Harnessing curcumin in a multifunctional biodegradable metal-organic framework (bio-MOF) for targeted colorectal cancer theranostics. Drug Deliv Transl Res. 2025;15(5):1719\u201338.","journal-title":"Drug Deliv Transl Res"},{"issue":"14","key":"4887_CR37","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.7150\/thno.72509","volume":"12","author":"Q Mao","year":"2022","unstructured":"Mao Q, Min J, Zeng R, Liu H, Li H, Zhang C, et al. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy. Theranostics. 2022;12(14):6088\u2013105.","journal-title":"Theranostics"},{"key":"4887_CR38","doi-asserted-by":"publisher","first-page":"1405252","DOI":"10.3389\/fphar.2024.1405252","volume":"15","author":"YB Zhang","year":"2024","unstructured":"Zhang YB, Wang JF, Wang MX, Peng J, Kong XD, Tian J. Nano-based drug delivery systems for active ingredients from traditional Chinese medicine: Harnessing the power of nanotechnology. Front Pharmacol. 2024;15:1405252.","journal-title":"Front Pharmacol"},{"key":"4887_CR39","doi-asserted-by":"publisher","first-page":"157291","DOI":"10.1016\/j.phymed.2025.157291","volume":"148","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Li Y, Lu M, Jia Z, Wan T, Li Z, et al. Baicalein specifically suppresses microsatellite instability colorectal cancer by targeting adenosylhomocysteinase to inhibit histone H3 lysine 4 trimethylation-mediated cancer stemness. Phytomedicine. 2025;148:157291.","journal-title":"Phytomedicine"},{"issue":"1","key":"4887_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12951-025-03378-y","volume":"23","author":"H Zheng","year":"2025","unstructured":"Zheng H, Chen Y, Luo W, Han S, Sun M, Lin M, et al. Integration of active ingredients from traditional Chinese medicine with nano-delivery systems for tumor immunotherapy. J Nanobiotechnol. 2025;23(1):357.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"4887_CR41","first-page":"100902","volume":"19","author":"Y Huang","year":"2024","unstructured":"Huang Y, Fan H, Ti H. Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy. Asian J Pharm Sci. 2024;19(2):100902.","journal-title":"Asian J Pharm Sci"},{"key":"4887_CR42","doi-asserted-by":"publisher","first-page":"1614640","DOI":"10.3389\/fimmu.2025.1614640","volume":"16","author":"H Piao","year":"2025","unstructured":"Piao H, Jiang Y, Jin S, Shi J, Yu J, Wang W, et al. Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy. Front Immunol. 2025;16:1614640.","journal-title":"Front Immunol"},{"issue":"12","key":"4887_CR43","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","volume":"25","author":"KB Kennel","year":"2025","unstructured":"Kennel KB, Greten FR. The immune microenvironment of colorectal cancer. Nat Rev Cancer. 2025;25(12):945\u201364.","journal-title":"Nat Rev Cancer"},{"key":"4887_CR44","doi-asserted-by":"publisher","first-page":"1574327","DOI":"10.3389\/fimmu.2025.1574327","volume":"16","author":"H Yu","year":"2025","unstructured":"Yu H, Yang R, Li M, Li D, Xu Y. The role of Treg cells in colorectal cancer and the immunotherapy targeting Treg cells. Front Immunol. 2025;16:1574327.","journal-title":"Front Immunol"},{"issue":"1","key":"4887_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12967-024-04856-x","volume":"22","author":"S Hou","year":"2024","unstructured":"Hou S, Zhao Y, Chen J, Lin Y, Qi X. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives. J Transl Med. 2024;22(1):62.","journal-title":"J Transl Med"},{"issue":"12","key":"4887_CR46","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.3390\/cancers12123850","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Rajput A, Jin N, Wang J. Mechanisms of Immunosuppression in Colorectal Cancer. Cancers (Basel). 2020;12(12):3850.","journal-title":"Cancers (Basel)"},{"key":"4887_CR47","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3389\/fimmu.2020.01526","volume":"11","author":"I Sieminska","year":"2020","unstructured":"Sieminska I, Baran J. Myeloid-Derived Suppressor Cells in Colorectal Cancer. Front Immunol. 2020;11:1526.","journal-title":"Front Immunol"},{"issue":"10","key":"4887_CR48","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00262-021-02886-8","volume":"70","author":"R Liang","year":"2021","unstructured":"Liang R, Zhu X, Lan T, Ding D, Zheng Z, Chen T, et al. TIGIT promotes CD8(+)T cells exhaustion and predicts poor prognosis of colorectal cancer. Cancer Immunol Immunother. 2021;70(10):2781\u201393.","journal-title":"Cancer Immunol Immunother"},{"key":"4887_CR49","doi-asserted-by":"publisher","first-page":"110207","DOI":"10.1016\/j.intimp.2023.110207","volume":"119","author":"A Meyiah","year":"2023","unstructured":"Meyiah A, Mahmoodi Chalbatani G, Al-Mterin MA, Malekraeisi MA, Murshed K, Elkord E. Co-expression of PD-1 with TIGIT or PD-1 with TIM-3 on tumor-infiltrating CD8(+) T cells showed synergistic effects on improved disease-free survival in treatment-na\u00efve CRC patients. Int Immunopharmacol. 2023;119:110207.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"4887_CR50","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.trecan.2022.06.010","volume":"8","author":"M Wagner","year":"2022","unstructured":"Wagner M, Koyasu S. Cancer immunosurveillance by ILC2s. Trends Cancer. 2022;8(10):792\u20134.","journal-title":"Trends Cancer"},{"issue":"8045","key":"4887_CR51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-024-08194-2","volume":"637","author":"M Wagner","year":"2025","unstructured":"Wagner M, Nishikawa H, Koyasu S. Reinventing type 2 immunity in cancer. Nature. 2025;637(8045):296\u2013303.","journal-title":"Nature"},{"issue":"1","key":"4887_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21(1):11\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"17","key":"4887_CR53","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1158\/1078-0432.CCR-24-0468","volume":"30","author":"AM Johansen","year":"2024","unstructured":"Johansen AM, Forsythe SD, McGrath CT, Barker G, Jimenez H, Paluri RK, et al. TGF\u03b2 in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance. Clin Cancer Res. 2024;30(17):3676\u201387.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4887_CR54","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/iub.70009","volume":"77","author":"Y Li","year":"2025","unstructured":"Li Y, Jiang X, Cao H, Wu X, Zhang H, Ma H, et al. The cGAS-STING-related signature affects the prognosis of colorectal cancer through its regulation of multiple immune cells. IUBMB Life. 2025;77(3):e70009.","journal-title":"IUBMB Life"},{"key":"4887_CR55","doi-asserted-by":"publisher","first-page":"1709908","DOI":"10.3389\/fimmu.2025.1709908","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Tang X, Chen S, Ye Y, Mao F. cGAS-STING signaling: a therapeutic target in inflammatory bowel disease and related colorectal cancer. Front Immunol. 2025;16:1709908.","journal-title":"Front Immunol"},{"issue":"1","key":"4887_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40364-024-00606-9","volume":"12","author":"B Luo","year":"2024","unstructured":"Luo B, Zhang S, Yu X, Tan D, Wang Y, Wang M. Gasdermin E benefits CD8(+)T cell mediated anti-immunity through mitochondrial damage to activate cGAS-STING-interferon\u03b2 axis in colorectal cancer. Biomark Res. 2024;12(1):59.","journal-title":"Biomark Res"},{"issue":"1","key":"4887_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40364-025-00750-w","volume":"13","author":"W Zhang","year":"2025","unstructured":"Zhang W, Huang X. Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy. Biomark Res. 2025;13(1):43.","journal-title":"Biomark Res"},{"issue":"1","key":"4887_CR58","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13046-025-03544-y","volume":"44","author":"WJ Li","year":"2025","unstructured":"Li WJ, Dong GH, Bi Y, Han YY, Sun LL, Wang T, et al. The cGAS\u2013STING pathway in colorectal cancer: bridging innate immunity and therapeutic strategies. J Exp Clin Cancer Res. 2025;44(1):286.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4887_CR59","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13045-022-01358-5","volume":"15","author":"X Zhong","year":"2022","unstructured":"Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, et al. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 2022;15(1):160.","journal-title":"J Hematol Oncol"},{"key":"4887_CR60","doi-asserted-by":"crossref","unstructured":"Garlatti V, Consonni FM, Ballerini G, Incerti M, Balboni A, Cassatella M et al. Myeloid metabolism and its role in immunotherapy of cancer. J Immunother Cancer. 2025;13(11):e012127.","DOI":"10.1136\/jitc-2025-012127"},{"key":"4887_CR61","doi-asserted-by":"publisher","first-page":"1757513","DOI":"10.3389\/fimmu.2026.1757513","volume":"17","author":"W Zhang","year":"2026","unstructured":"Zhang W, Jin C, Liu S, Wan X, Li Y, Liu J, et al. Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities. Front Immunol. 2026;17:1757513.","journal-title":"Front Immunol"},{"issue":"1","key":"4887_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40164-022-00334-6","volume":"11","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zheng Y, Chen Y, Yin Y, Chen Y, Chen Q, et al. Gut fungi enhances immunosuppressive function of myeloid-derived suppressor cells by activating PKM2-dependent glycolysis to promote colorectal tumorigenesis. Exp Hematol Oncol. 2022;11(1):88.","journal-title":"Exp Hematol Oncol"},{"issue":"11","key":"4887_CR63","doi-asserted-by":"publisher","first-page":"e70415","DOI":"10.1002\/mco2.70415","volume":"6","author":"C Fan","year":"2025","unstructured":"Fan C, Zhu W, Chen Y, Zhu W, Ding J. Cancer-Associated Fibroblasts: Origin, Classification, Tumorigenicity, and Targeting for Cancer Therapy. MedComm (2020). 2025;6(11):e70415.","journal-title":"MedComm (2020)"},{"issue":"14","key":"4887_CR64","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","volume":"75","author":"A Lo","year":"2015","unstructured":"Lo A, Wang LS, Scholler J, Monslow J, Avery D, Newick K, et al. Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. Cancer Res. 2015;75(14):2800\u201310.","journal-title":"Cancer Res"},{"issue":"6","key":"4887_CR65","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/cancers15061899","volume":"15","author":"K Wright","year":"2023","unstructured":"Wright K, Ly T, Kriet M, Czirok A, Thomas SM. Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers. Cancers (Basel). 2023;15(6):1899.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4887_CR66","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.nano.2012.07.002","volume":"9","author":"S Torosean","year":"2013","unstructured":"Torosean S, Flynn B, Axelsson J, Gunn J, Samkoe KS, Hasan T, et al. Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure. Nanomedicine. 2013;9(2):151\u20138.","journal-title":"Nanomedicine"},{"issue":"4","key":"4887_CR67","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.14218\/OnA.2025.00021","volume":"3","author":"J Di","year":"2025","unstructured":"Di J, Liu J, Zhang X. Mechanisms Underlying Immunotherapy Resistance in Microsatellite-stable Colorectal Cancer. Oncol Adv. 2025;3(4):e00021\u2013e.","journal-title":"Oncol Adv"},{"issue":"6","key":"4887_CR68","doi-asserted-by":"publisher","first-page":"188997","DOI":"10.1016\/j.bbcan.2023.188997","volume":"1878","author":"Z Li","year":"2023","unstructured":"Li Z, Yin P. Tumor microenvironment diversity and plasticity in cancer multidrug resistance. Biochim Biophys Acta Rev Cancer. 2023;1878(6):188997.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"17","key":"4887_CR69","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","volume":"31","author":"RK Jain","year":"2013","unstructured":"Jain RK. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol. 2013;31(17):2205\u201318.","journal-title":"J Clin Oncol"},{"issue":"9","key":"4887_CR70","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1172\/JCI79434","volume":"126","author":"AW Lund","year":"2016","unstructured":"Lund AW, Wagner M, Fankhauser M, Steinskog ES, Broggi MA, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126(9):3389\u2013402.","journal-title":"J Clin Invest"},{"issue":"29","key":"4887_CR71","doi-asserted-by":"publisher","first-page":"45789","DOI":"10.18632\/oncotarget.9953","volume":"7","author":"ES Steinskog","year":"2016","unstructured":"Steinskog ES, Sagstad SJ, Wagner M, Karlsen TV, Yang N, Markhus CE, et al. Impaired lymphatic function accelerates cancer growth. Oncotarget. 2016;7(29):45789\u2013802.","journal-title":"Oncotarget"},{"key":"4887_CR72","doi-asserted-by":"crossref","unstructured":"Fankhauser M, Broggi MAS, Potin L, Bordry N, Jeanbart L, Lund AW et al. Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. Sci Transl Med. 2017;9(407):eaal4712.","DOI":"10.1126\/scitranslmed.aal4712"},{"issue":"10","key":"4887_CR73","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.ajpath.2019.06.010","volume":"189","author":"M Wagner","year":"2019","unstructured":"Wagner M, Steinskog ES, Wiig H. Blockade of Lymphangiogenesis Shapes Tumor-Promoting Adipose Tissue Inflammation. Am J Pathol. 2019;189(10):2102\u201314.","journal-title":"Am J Pathol"},{"issue":"12","key":"4887_CR74","first-page":"1177","volume":"22","author":"L Yang","year":"2024","unstructured":"Yang L, Wang Y, Ye X, Liu Q, Qu D, Chen Y. Traditional Chinese medicine-based drug delivery systems for anti-tumor therapies. Chin J Nat Med. 2024;22(12):1177\u201392.","journal-title":"Chin J Nat Med"},{"key":"4887_CR75","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fphar.2019.00152","volume":"10","author":"KE Wong","year":"2019","unstructured":"Wong KE, Ngai SC, Chan KG, Lee LH, Goh BH, Chuah LH. Curcumin Nanoformulations for Colorectal Cancer: A Review. Front Pharmacol. 2019;10:152.","journal-title":"Front Pharmacol"},{"issue":"16","key":"4887_CR76","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1039\/D2TB00225F","volume":"10","author":"D Wei","year":"2022","unstructured":"Wei D, Yang H, Zhang Y, Zhang X, Wang J, Wu X, et al. Nano-traditional Chinese medicine: a promising strategy and its recent advances. J Mater Chem B. 2022;10(16):2973\u201394.","journal-title":"J Mater Chem B"},{"issue":"4","key":"4887_CR77","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2174\/1872210514666200604145755","volume":"14","author":"P Pandey","year":"2020","unstructured":"Pandey P, Gulati N, Makhija M, Purohit D, Dureja H. Nanoemulsion: A Novel Drug Delivery Approach for Enhancement of Bioavailability. Recent Pat Nanotechnol. 2020;14(4):276\u201393.","journal-title":"Recent Pat Nanotechnol"},{"issue":"9","key":"4887_CR78","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, et al. Polymeric Nanoparticles for Drug Delivery. Chem Rev. 2024;124(9):5505\u2013616.","journal-title":"Chem Rev"},{"key":"4887_CR79","doi-asserted-by":"publisher","first-page":"114466","DOI":"10.1016\/j.addr.2022.114466","volume":"188","author":"Y Lv","year":"2022","unstructured":"Lv Y, Wu W, Corpstein CD, Li T, Lu Y. Biological and intracellular fates of drug nanocrystals through different delivery routes: Recent development enabled by bioimaging and PK modeling. Adv Drug Deliv Rev. 2022;188:114466.","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"4887_CR80","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.7150\/thno.40068","volume":"10","author":"L Fusco","year":"2020","unstructured":"Fusco L, Gazzi A, Peng G, Shin Y, Vranic S, Bedognetti D, et al. Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics. Theranostics. 2020;10(12):5435\u201388.","journal-title":"Theranostics"},{"issue":"Pt 1","key":"4887_CR81","doi-asserted-by":"publisher","first-page":"138849","DOI":"10.1016\/j.jcis.2025.138849","volume":"702","author":"J Lu","year":"2026","unstructured":"Lu J, Li Y, Qin X, Wang Z, Ouyang A, Su B, et al. A clinically inspired olsalazine-based metal-organic framework enables a universal nanodrugs platform for diverse disease. J Colloid Interface Sci. 2026;702(Pt 1):138849.","journal-title":"J Colloid Interface Sci"},{"key":"4887_CR82","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.2147\/IJN.S422944","volume":"18","author":"J Lu","year":"2023","unstructured":"Lu J, Wang Z, Cai D, Lin X, Huang X, Yuan Z, et al. Carrier-Free Binary Self-Assembled Nanomedicines Originated from Traditional Herb Medicine with Multifunction to Accelerate MRSA-Infected Wound Healing by Antibacterial, Anti-Inflammation and Promoting Angiogenesis. Int J Nanomed. 2023;18:4885\u2013906.","journal-title":"Int J Nanomed"},{"issue":"5","key":"4887_CR83","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","volume":"18","author":"A Spada","year":"2021","unstructured":"Spada A, Emami J, Tuszynski JA, Lavasanifar A. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. Mol Pharm. 2021;18(5):1862\u201394.","journal-title":"Mol Pharm"},{"key":"4887_CR84","doi-asserted-by":"publisher","first-page":"923598","DOI":"10.3389\/fimmu.2022.923598","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C, Ju D, Zhang X. Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy. Front Immunol. 2022;13:923598.","journal-title":"Front Immunol"},{"issue":"1","key":"4887_CR85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ymthe.2020.11.030","volume":"29","author":"HA Dad","year":"2021","unstructured":"Dad HA, Gu TW, Zhu AQ, Huang LQ, Peng LH. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms. Mol Ther. 2021;29(1):13\u201331.","journal-title":"Mol Ther"},{"issue":"48","key":"4887_CR86","doi-asserted-by":"publisher","first-page":"43510","DOI":"10.1021\/acsomega.2c04098","volume":"7","author":"X Lin","year":"2022","unstructured":"Lin X, Huang X, Tian X, Yuan Z, Lu J, Nie X, et al. Natural Small-Molecule-Based Carrier-Free Self-Assembly Library Originated from Traditional Chinese Herbal Medicine. ACS Omega. 2022;7(48):43510\u201321.","journal-title":"ACS Omega"},{"issue":"47","key":"4887_CR87","doi-asserted-by":"publisher","first-page":"9735","DOI":"10.1039\/D2TB02025D","volume":"10","author":"L Huang","year":"2022","unstructured":"Huang L, Hu S, Fu YN, Wan Y, Li G, Wang X. Multicomponent carrier-free nanodrugs for cancer treatment. J Mater Chem B. 2022;10(47):9735\u201354.","journal-title":"J Mater Chem B"},{"issue":"8","key":"4887_CR88","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1002\/pca.3381","volume":"36","author":"Y Xie","year":"2025","unstructured":"Xie Y, Shen X, Xu F, Liang X. Research progress of nano-delivery systems for the active ingredients from traditional Chinese medicine. Phytochem Anal. 2025;36(8):2266\u201379.","journal-title":"Phytochem Anal"},{"issue":"3","key":"4887_CR89","first-page":"368","volume":"6","author":"NP Kar","year":"2025","unstructured":"Kar NP, Lin J, HassankhaniRad A, Li W, Aboushanab AR, Li Y, et al. Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. Smart Mater Med. 2025;6(3):368\u201386.","journal-title":"Smart Mater Med"},{"key":"4887_CR90","doi-asserted-by":"publisher","first-page":"115838","DOI":"10.1016\/j.addr.2026.115838","volume":"232","author":"D Mao","year":"2026","unstructured":"Mao D, Li B, Li J, Pan J, Wu Z, Feng N. Nanodrug delivery systems in tumor immunotherapy: From immune activation to tumor reprogramming. Adv Drug Deliv Rev. 2026;232:115838.","journal-title":"Adv Drug Deliv Rev"},{"key":"4887_CR91","doi-asserted-by":"crossref","unstructured":"Thamizhchelvan AM, Wells K, Pham J, Galhena A, Kim W. Nanomaterial-Enabled Modulation of Tumor-Associated Macrophages and Dendritic Cells to Enhance Cancer Immunotherapy. Nanomaterials (Basel). 2026;16(3):172.","DOI":"10.3390\/nano16030172"},{"key":"4887_CR92","doi-asserted-by":"crossref","unstructured":"Kong X, Zhang C, Hu H, Chen Y, Gao W, Chen R. Mechanisms and Applications of Manganese-Based Materials in Tumor Immunotherapy. Molecules. 2026;31(10):1704.","DOI":"10.3390\/molecules31101704"},{"key":"4887_CR93","doi-asserted-by":"publisher","first-page":"125753","DOI":"10.1016\/j.ijpharm.2025.125753","volume":"680","author":"N Jan","year":"2025","unstructured":"Jan N, Shah H, Shi G. Biomimetic approaches against accelerated blood clearance (ABC) phenomenon of nanoparticulate drug delivery systems. Int J Pharm. 2025;680:125753.","journal-title":"Int J Pharm"},{"key":"4887_CR94","doi-asserted-by":"publisher","first-page":"1745590","DOI":"10.3389\/fphar.2026.1745590","volume":"17","author":"X Chen","year":"2026","unstructured":"Chen X, Li H, Chen J, Hou B, Tian Z, Qiu W, et al. Induction of immunogenic cell death by active components of natural products reshaping the tumor microenvironment for enhanced antitumor immunity. Front Pharmacol. 2026;17:1745590.","journal-title":"Front Pharmacol"},{"key":"4887_CR95","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.2147\/IJN.S419712","volume":"18","author":"C He","year":"2023","unstructured":"He C, Ding H, Li L, Chen J, Mo X, Ding Y, et al. Gold Nanoparticles Enhance the Ability of Radiotherapy to Induce Immunogenic Cell Death in Glioblastoma. Int J Nanomed. 2023;18:5701\u201312.","journal-title":"Int J Nanomed"},{"key":"4887_CR96","doi-asserted-by":"crossref","unstructured":"Mianowska M, Zaremba-Czogalla M, Zygmunt A, Mahmud M, S\u00fcss R, Gubernator J. Dual Role of Vitamin C-Encapsulated Liposomal Berberine in Effective Colon Anticancer Immunotherapy. Pharmaceuticals (Basel). 2023;17(1):5.","DOI":"10.3390\/ph17010005"},{"key":"4887_CR97","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jconrel.2022.07.042","volume":"349","author":"Z Wang","year":"2022","unstructured":"Wang Z, Li W, Park J, Gonzalez KM, Scott AJ, Lu J. Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade. J Control Release. 2022;349:929\u201339.","journal-title":"J Control Release"},{"issue":"1","key":"4887_CR98","first-page":"100993","volume":"20","author":"F Wu","year":"2025","unstructured":"Wu F, An X, Li S, Qiu C, Zhu Y, Ye Z, et al. Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: A STAT3 signaling pathway modulation approach. Asian J Pharm Sci. 2025;20(1):100993.","journal-title":"Asian J Pharm Sci"},{"issue":"11","key":"4887_CR99","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.1021\/acsnano.9b02875","volume":"13","author":"J Zhang","year":"2019","unstructured":"Zhang J, Shen L, Li X, Song W, Liu Y, Huang L. Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer. ACS Nano. 2019;13(11):12511\u201324.","journal-title":"ACS Nano"},{"issue":"39","key":"4887_CR100","doi-asserted-by":"publisher","first-page":"18570","DOI":"10.1039\/D4NR01497A","volume":"16","author":"F Cheng","year":"2024","unstructured":"Cheng F, He L, Wang J, Lai L, Ma L, Qu K, et al. Synergistic immunotherapy with a calcium-based nanoinducer: evoking pyroptosis and remodeling tumor-associated macrophages for enhanced antitumor immune response. Nanoscale. 2024;16(39):18570\u201383.","journal-title":"Nanoscale"},{"issue":"1","key":"4887_CR101","doi-asserted-by":"publisher","first-page":"e10610","DOI":"10.1002\/btm2.10610","volume":"9","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Guo G, Wang H, Peng B, Lin Y, Qu G, et al. Curcumin\/L-OHP co-loaded HAP for cGAS-STING pathway activation to enhance the natural immune response in colorectal cancer. Bioeng Transl Med. 2024;9(1):e10610.","journal-title":"Bioeng Transl Med"},{"key":"4887_CR102","doi-asserted-by":"publisher","first-page":"121856","DOI":"10.1016\/j.biomaterials.2022.121856","volume":"290","author":"L Cao","year":"2022","unstructured":"Cao L, Tian H, Fang M, Xu Z, Tang D, Chen J, et al. Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy. Biomaterials. 2022;290:121856.","journal-title":"Biomaterials"},{"issue":"3","key":"4887_CR103","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.7150\/thno.38287","volume":"10","author":"J Sun","year":"2020","unstructured":"Sun J, Chen Y, Xu J, Song X, Wan Z, Du Y, et al. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy. Theranostics. 2020;10(3):1136\u201350.","journal-title":"Theranostics"},{"issue":"10","key":"4887_CR104","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2217\/nnm.12.29","volume":"7","author":"JR Kanwar","year":"2012","unstructured":"Kanwar JR, Mahidhara G, Kanwar RK. Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy. Nanomed (Lond). 2012;7(10):1521\u201350.","journal-title":"Nanomed (Lond)"},{"issue":"6","key":"4887_CR105","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/02652048.2017.1339739","volume":"34","author":"M Xiong","year":"2017","unstructured":"Xiong M, Lei Q, You X, Gao T, Song X, Xia Y, et al. Mannosylated liposomes improve therapeutic effects of paclitaxel in colon cancer models. J Microencapsul. 2017;34(6):513\u201321.","journal-title":"J Microencapsul"},{"key":"4887_CR106","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2147\/IJN.S290731","volume":"16","author":"Y Hu","year":"2021","unstructured":"Hu Y, Zhang K, Zhu X, Zheng X, Wang C, Niu X, et al. Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K\/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis. Int J Nanomed. 2021;16:2173\u201386.","journal-title":"Int J Nanomed"},{"key":"4887_CR107","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.2147\/IJN.S110251","volume":"11","author":"NN Parayath","year":"2016","unstructured":"Parayath NN, Nehoff H, Norton SE, Highton AJ, Taurin S, Kemp RA, et al. Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model. Int J Nanomed. 2016;11:3979\u201391.","journal-title":"Int J Nanomed"},{"issue":"3","key":"4887_CR108","doi-asserted-by":"publisher","first-page":"409","DOI":"10.15171\/apb.2019.048","volume":"9","author":"J Rashedi","year":"2019","unstructured":"Rashedi J, Ghorbani Haghjo A, Mesgari Abbasi M, Dastranj Tabrizi A, Yaqoubi S, Sanajou D, et al. Anti-tumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar Rats. Adv Pharm Bull. 2019;9(3):409\u201315.","journal-title":"Adv Pharm Bull"},{"key":"4887_CR109","first-page":"2051","volume":"10","author":"G Xu","year":"2015","unstructured":"Xu G, Shi H, Ren L, Gou H, Gong D, Gao X, et al. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles. Int J Nanomed. 2015;10:2051\u201363.","journal-title":"Int J Nanomed"},{"key":"4887_CR110","doi-asserted-by":"crossref","unstructured":"Serini S, Cassano R, Corsetto PA, Rizzo AM, Calviello G, Trombino S. Omega-3 PUFA Loaded in Resveratrol-Based Solid Lipid Nanoparticles: Physicochemical Properties and Antineoplastic Activities in Human Colorectal Cancer Cells In Vitro. Int J Mol Sci. 2018;19(2):586.","DOI":"10.3390\/ijms19020586"},{"issue":"9","key":"4887_CR111","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00210-014-0994-0","volume":"387","author":"TE Schwingel","year":"2014","unstructured":"Schwingel TE, Klein CP, Nicoletti NF, Dora CL, Hadrich G, Bica CG, et al. Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice. Naunyn Schmiedebergs Arch Pharmacol. 2014;387(9):837\u201348.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4887_CR112","doi-asserted-by":"crossref","unstructured":"Wang X, Li D, Li G, Chen J, Yang Y, Bian L et al. Enhanced Therapeutic Potential of Hybrid Exosomes Loaded with Paclitaxel for Cancer Therapy. Int J Mol Sci. 2024;25(7):3645.","DOI":"10.3390\/ijms25073645"},{"key":"4887_CR113","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.2147\/IJN.S408521","volume":"18","author":"F Huang","year":"2023","unstructured":"Huang F, Zhang Q, Xiao J, Zhang X, Han X, Shi X, et al. Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells. Int J Nanomed. 2023;18:2261\u201373.","journal-title":"Int J Nanomed"},{"key":"4887_CR114","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2147\/IJN.S502076","volume":"20","author":"Y Xie","year":"2025","unstructured":"Xie Y, Zhu M, Bao H, Chen K, Wang S, Dai J, et al. Enhanced Antitumor Efficacy and Reduced Toxicity in Colorectal Cancer Using a Novel Multifunctional Rg3- Targeting Nanosystem Encapsulated with Oxaliplatin and Calcium Peroxide. Int J Nanomed. 2025;20:1021\u201346.","journal-title":"Int J Nanomed"},{"issue":"8","key":"4887_CR115","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.7150\/thno.40318","volume":"10","author":"R Zhao","year":"2020","unstructured":"Zhao R, Du S, Liu Y, Lv C, Song Y, Chen X, et al. Mucoadhesive-to-penetrating controllable peptosomes-in-microspheres co-loaded with anti-miR-31 oligonucleotide and Curcumin for targeted colorectal cancer therapy. Theranostics. 2020;10(8):3594\u2013611.","journal-title":"Theranostics"},{"issue":"10","key":"4887_CR116","doi-asserted-by":"publisher","first-page":"2400324","DOI":"10.1002\/smsc.202400324","volume":"4","author":"N Sang","year":"2024","unstructured":"Sang N, Qi Y, Nishimura S, Miyako E. Biomimetic Functional Nanocomplexes for Photothermal Cancer Chemoimmunotheranostics. Small Sci. 2024;4(10):2400324.","journal-title":"Small Sci"},{"key":"4887_CR117","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.2147\/IJN.S287732","volume":"16","author":"A Yalikong","year":"2021","unstructured":"Yalikong A, Li XQ, Zhou PH, Qi ZP, Li B, Cai SL, et al. A Triptolide Loaded HER2-Targeted Nano-Drug Delivery System Significantly Suppressed the Proliferation of HER2-Positive and BRAF Mutant Colon Cancer. Int J Nanomed. 2021;16:2323\u201335.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4887_CR118","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/10717544.2021.1921077","volume":"28","author":"F Gong","year":"2021","unstructured":"Gong F, Ma JC, Jia J, Li FZ, Wu JL, Wang S, et al. Synergistic effect of the anti-PD-1 antibody with blood stable and reduction sensitive curcumin micelles on colon cancer. Drug Deliv. 2021;28(1):930\u201342.","journal-title":"Drug Deliv"},{"key":"4887_CR119","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jcis.2022.02.132","volume":"617","author":"J Liu","year":"2022","unstructured":"Liu J, Li L, Zhang B, Xu ZP. MnO(2)-shelled Doxorubicin\/Curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy. J Colloid Interface Sci. 2022;617:315\u201325.","journal-title":"J Colloid Interface Sci"},{"issue":"2","key":"4887_CR120","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1021\/acs.molpharmaceut.7b00808","volume":"15","author":"L Meng","year":"2018","unstructured":"Meng L, Cheng Y, Gan S, Zhang Z, Tong X, Xu L, et al. Facile Deposition of Manganese Dioxide to Albumin-Bound Paclitaxel Nanoparticles for Modulation of Hypoxic Tumor Microenvironment To Improve Chemoradiation Therapy. Mol Pharm. 2018;15(2):447\u201357.","journal-title":"Mol Pharm"},{"issue":"5","key":"4887_CR121","doi-asserted-by":"publisher","first-page":"279","DOI":"10.55730\/1300-0152.2704","volume":"48","author":"FRP Dewi","year":"2024","unstructured":"Dewi FRP, Marviella ST, Wahyuningsih SPA, Rosyidah A, Lim V, In LLA, et al. Antimetastatic effect of nanodiamond-conjugated quercetin against colon cancer: an in vivo study. Turk J Biol. 2024;48(5):279\u201389.","journal-title":"Turk J Biol"},{"key":"4887_CR122","doi-asserted-by":"publisher","first-page":"119337","DOI":"10.1016\/j.ijpharm.2020.119337","volume":"584","author":"T Fourniols","year":"2020","unstructured":"Fourniols T, Bastien E, Canevat A, Feron O, Pr\u00e9at V. Inhibition of colorectal cancer-associated fibroblasts by lipid nanocapsules loaded with acriflavine or paclitaxel. Int J Pharm. 2020;584:119337.","journal-title":"Int J Pharm"},{"issue":"10","key":"4887_CR123","doi-asserted-by":"publisher","first-page":"13249","DOI":"10.1007\/s00210-025-04175-y","volume":"398","author":"L Wu","year":"2025","unstructured":"Wu L, Wu J, Wang X, Xu Y, Lin Z, Chen J, et al. Natural product-based nanotechnological formulations for colorectal cancer treatment. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(10):13249\u201363.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4887_CR124","doi-asserted-by":"publisher","first-page":"114826","DOI":"10.1016\/j.jconrel.2026.114826","volume":"393","author":"W Chen","year":"2026","unstructured":"Chen W, Raza F, Li K, Xiao H, Song J, Zafar H, et al. Traditional Chinese medicine-based self-assembled nanomaterials for cancer therapy. J Control Release. 2026;393:114826.","journal-title":"J Control Release"},{"issue":"5","key":"4887_CR125","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/pca.70073","volume":"37","author":"Y Xiong","year":"2026","unstructured":"Xiong Y, Geng H, Jiang W, Meng Y. Nanoparticle-Based Delivery Systems for Traditional Chinese Medicine in Cardiovascular Diseases: Advances and Challenges. Phytochem Anal. 2026;37(5):692\u2013715.","journal-title":"Phytochem Anal"},{"key":"4887_CR126","doi-asserted-by":"crossref","unstructured":"Jandang W, Saokham P, Prathumwon C, Okonogi S, Ampasavate C. Quality by Design-Based Scale-Up and Industrial Development of Turmeric Extract-Loaded Nanostructured Lipid Carriers. Pharmaceutics. 2026;18(4):492.","DOI":"10.3390\/pharmaceutics18040492"},{"key":"4887_CR127","doi-asserted-by":"publisher","first-page":"1366489","DOI":"10.3389\/fimmu.2024.1366489","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Guo Z, Shen M, Xie Q, Xiang H. Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis. Front Immunol. 2024;15:1366489.","journal-title":"Front Immunol"},{"issue":"1","key":"4887_CR128","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8(1):293.","journal-title":"Signal Transduct Target Ther"},{"issue":"40","key":"4887_CR129","doi-asserted-by":"publisher","first-page":"33390","DOI":"10.1039\/D5RA05296C","volume":"15","author":"S Preetam","year":"2025","unstructured":"Preetam S, Lata S, Aditi, Bora J, Thapliyal S, Mehta S, et al. Exosome-driven biohybrid nanorobots: bridging nature and nanotechnology in biomedical innovation. RSC Adv. 2025;15(40):33390\u2013409.","journal-title":"RSC Adv"},{"issue":"4","key":"4887_CR130","first-page":"263","volume":"2","author":"E Wang","year":"2022","unstructured":"Wang E, Xiang K, Zhang Y, Wang XF. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models. J Natl Cancer Cent. 2022;2(4):263\u201376.","journal-title":"J Natl Cancer Cent"},{"issue":"38","key":"4887_CR131","doi-asserted-by":"publisher","first-page":"e2403024","DOI":"10.1002\/smll.202403024","volume":"20","author":"J Liu","year":"2024","unstructured":"Liu J, Li B, Li L, Ming X, Xu ZP. Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy. Small. 2024;20(38):e2403024.","journal-title":"Small"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04887-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:04:03Z","timestamp":1790168643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04887-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":131,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4887"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04887-x","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article is a review study and does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article does not involve human participants.","order":2,"name":"Ethics","label":"Consent for participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article does not contain any individual person\u2019s data in any form.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"467"}}